2nd Apr 2007 17:11
AstraZeneca PLC02 April 2007 Dealing by Directors Companies Act 1985 Sections 324/329 Transaction by Persons Discharging Managerial Responsibilities Disclosure Rules DR 3.1.2R We hereby inform you that on 30 March 2007 the following Directors ofAstraZeneca PLC were granted options under the AstraZeneca Share Option Planover the Company's USD0.25 Ordinary Shares. Number of shares over which option is granted Exercise price per Period when Total number of shares share exercisable under optionName of Director D R Brennan 128,462 2744p 30.3.10-29.3.17 See below J R Symonds 60,349 2744p 30.3.10-29.3.17 423,769 J S Patterson 44,142 2744p 30.3.10-29.3.17 236,716 The options will become exercisable on 30 March 2010 subject to certainperformance conditions. The conditions, which will not be subject to anyretesting, are that the earnings per share of the Company must increase by theincrease in the UK Retail Prices Index plus 5% per annum on average over threeyears, and that no significant unforeseen event has taken place which, in thereasonable opinion of the Remuneration Committee, has resulted in majorreputational damage to AstraZeneca, and the circumstances of which areexceptional enough to justify the option not vesting and becoming exercisable.Failure to satisfy either or both of these conditions will result in the lapseof the option in its entirety. David R Brennan, a Director of the Company, has previously received grants ofoptions over the Company's American Depositary Shares (ADSs). One ADS equalsone Ordinary Share. Following the grant of options referred to above, DavidBrennan has options over 239,103 Ordinary Shares and 355,246 ADSs. G H R Musker Company Secretary 2 April 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca